⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
DXR News
Daxor Corporation Common Stock
Daxor Corporation Announces Transition To Securities Exchange Act of 1934 Reporting Company, Reaffirming Focus on Core Blood Volume Analysis and Diagnostic Business
globenewswire.com
DXR
Daxor Corporation Announces $9 Million Registered Direct Offering
globenewswire.com
DXR
Daxor Fuels Growth with Three New Facility Adoptions and Deployment of Next-Generation BVA Analyzer
globenewswire.com
DXR
Daxor’s New BVA Technology To Be Showcased At MedAxiom CV Transforum Fall '25
globenewswire.com
DXR
Daxor Unveils New FDA-Cleared BVA Analyzer Amid Strong Market Demand and Pivotal Clinical Data at HFSA
globenewswire.com
DXR